X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (218) 218
Patent (15) 15
Newspaper Article (8) 8
Publication (8) 8
Book / eBook (3) 3
Book Review (1) 1
Reference (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
male (65) 65
female (64) 64
middle aged (54) 54
index medicus (53) 53
diabetes (44) 44
adult (38) 38
medicine, general & internal (37) 37
medicine & public health (29) 29
internal medicine (27) 27
endocrinology & metabolism (26) 26
type 2 diabetes (25) 25
aged (24) 24
endocrinology (24) 24
medicine/public health, general (24) 24
gastroenterology (23) 23
pneumology/respiratory system (23) 23
diabetes mellitus (19) 19
austria (18) 18
diabetes mellitus, type 2 - drug therapy (18) 18
glucose tolerance test (17) 17
mortality (16) 16
risk factors (16) 16
treatment outcome (16) 16
diabetes mellitus, type 2 - blood (15) 15
obesity (15) 15
prospective studies (15) 15
risk (15) 15
abridged index medicus (14) 14
glucose (14) 14
mellitus (14) 14
practice guidelines as topic (14) 14
hypoglycemic agents - therapeutic use (13) 13
insulin (13) 13
research (13) 13
blood glucose - metabolism (12) 12
evidence-based medicine (12) 12
health aspects (12) 12
hypoglycemic agents - administration & dosage (12) 12
insulin - metabolism (12) 12
prevention (12) 12
surgery (12) 12
austria - epidemiology (11) 11
blood glucose - analysis (11) 11
body mass index (11) 11
diabetics (11) 11
double-blind method (11) 11
glycated hemoglobin a - metabolism (11) 11
insulin - blood (11) 11
insulin resistance (11) 11
metabolism (11) 11
bariatric surgery (10) 10
cardiovascular disease (10) 10
care and treatment (10) 10
disease (10) 10
glucose control (10) 10
insulin therapy (10) 10
weight loss (10) 10
cardiovascular diseases - etiology (9) 9
diabetes mellitus, type 2 - complications (9) 9
diabetes mellitus, type 2 - prevention & control (9) 9
drug therapy (9) 9
incidence (9) 9
prevalence (9) 9
sensitivity (9) 9
c-peptide - blood (8) 8
cardiovascular diseases (8) 8
complications (8) 8
efficacy (8) 8
hyperglycemia (8) 8
outcomes (8) 8
therapy (8) 8
biomarkers - blood (7) 7
blasting (7) 7
blood pressure (7) 7
cardiac & cardiovascular systems (7) 7
cardiovascular diseases - mortality (7) 7
clinical medicine (7) 7
diabetes mellitus, type 1 - blood (7) 7
diabetes mellitus, type 2 - diagnosis (7) 7
diabetic nephropathy (7) 7
drug administration schedule (7) 7
heating (7) 7
hypoglycemic agents - adverse effects (7) 7
insulin secretion (7) 7
lighting (7) 7
mechanical engineering (7) 7
original (7) 7
prognosis (7) 7
resistance (7) 7
risk-factors (7) 7
time factors (7) 7
weapons (7) 7
weight-loss (7) 7
adolescent (6) 6
analysis (6) 6
blood glucose - drug effects (6) 6
blood-pressure (6) 6
body weight (6) 6
cardiovascular diseases - epidemiology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10077, pp. 1399 - 1409
Summary Background Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials... 
Internal Medicine | 3.0 MG | REGRESSION | MEDICINE, GENERAL & INTERNAL | OBESE SUBJECTS | LIFE-STYLE | EXENATIDE | PREVENTION | NORMAL GLUCOSE REGULATION | Obesity - drug therapy | Glucagon-Like Peptide-1 Receptor - administration & dosage | Humans | Middle Aged | Body Weight - drug effects | Male | Weight Loss - drug effects | Liraglutide - pharmacology | Injections, Subcutaneous | Adult | Female | Placebos - administration & dosage | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Reduction Behavior | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptide 1 - pharmacology | Prediabetic State - prevention & control | Treatment Outcome | Prediabetic State - complications | Blood Glucose - drug effects | Prediabetic State - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Liraglutide - adverse effects | Obesity - epidemiology | Placebos - pharmacology | Incretins - therapeutic use | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Clinical trials | Glucose metabolism | Risk factors | Prediabetic state | Diabetes therapy | Exercise | Obesity | Evaluation | Diabetes mellitus | Health risks | Weight loss | Glucose | Evidence-based medicine | Placebo effect | Studies | Weight control | Randomization | Immunology | Classification | Weight reduction | Gastrointestinal surgery | Diabetes | Clinical medicine | Diagnosis | Autoimmune diseases | Risk management | Back pain | Physical activity | Gallbladder diseases | Body weight loss | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Hypertension | Risk reduction | Metabolism | Investigations | Nutrition research
Journal Article
Heart, ISSN 1355-6037, 10/2016, Volume 102, Issue 19, pp. 1544 - 1551
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2017, Volume 19, Issue 6, pp. 858 - 865
Journal Article
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 03/2018, Volume 20, Issue 3, pp. 689 - 697
Journal Article
Cell death & disease, ISSN 2041-4889, 10/2017, Volume 8, Issue 10, pp. e3135 - e3135
Soluble Axl (sAxl) was recently shown to be strongly released into the blood during liver fibrogenesis and hepatocellular carcinoma suggesting sAxl as a... 
TRANSIENT ELASTOGRAPHY | DIAGNOSTIC-VALUE | RECEPTOR TYROSINE KINASES | PLASMA-CONCENTRATIONS | DISEASE | MARKERS | STIFFNESS MEASUREMENT | FIBROTEST | HEPATITIS-C | FAILURE | CELL BIOLOGY | Cirrhosis | Liver diseases | Biopsy | Invasiveness | Liver | Fibrosis | Biomarkers | Albumin | Hepatocellular carcinoma | Axl protein | Original
Journal Article